Antimitotic Agents: all 5,052 studies that test it
Page 32 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for GlioblastomaSuspendedNCT01933815Phase 1/2
- Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic MelanomaWithdrawnNCT01933061Phase 2
- Dovitinib Plus Docetaxel in Gastric CancerCompletedNCT01921673Phase 1/2
- A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic LeukemiaActive, not recruitingNCT01920737Phase 2
- A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 ProteinCompletedNCT01918254Phase 1
- A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial CancerCompletedNCT01918124Phase 2
- Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell CancerCompletedNCT01914900Phase 2
- Ph II Cabazitaxel DD LiposarcomaCompletedNCT01913652Phase 2
- Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCWithdrawnNCT01913067Phase 2
- A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)CompletedNCT01911598Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid TumorsCompletedNCT01907685Phase 1
- A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast CancerStatus unknownNCT01907529Phase 2/3
- Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial CarcinomaWithdrawnNCT01907308Phase 2
- Colchicine for Acute Coronary SyndromesStatus unknownNCT01906749Phase 4
- Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast CancerActive, not recruitingNCT01898117Phase 2
- Molecularly Tailored Therapy for Pancreas CancerCompletedNCT01888978Phase 2
- Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young AdultsTerminatedNCT01887522Phase 2
- Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young AdultsCompletedNCT01884922Phase 1
- Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma PatientsStatus unknownNCT01884441Phase 2
- Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsActive, not recruitingNCT01873326Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the LungStatus unknownNCT01872403Phase 2
- Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma MultiformeCompletedNCT01866449Phase 2
- A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung CancerCompletedNCT01862081Phase 1
- Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsCompletedNCT01858883Phase 1/2
- Cabazitaxel in Relapsed and Metastatic NSCLCCompletedNCT01852578Phase 2
- Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHLCompletedNCT01851551Phase 1/2
- Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLCCompletedNCT01848613Phase 4
- Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast CancerStatus unknownNCT01848197Not applicable
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
- Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractCompletedNCT01844947Phase 1
- A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal CancerStatus unknownNCT01843829Phase 2
- Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric CancerCompletedNCT01839773Phase 3
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)CompletedNCT01839097Phase 1
- Oral Vinorelbine as Induction Chemotherapy Followed Concomitant ChemoradiotherapyCompletedNCT01839032Phase 2
- Phase I Study of LB-100 With Docetaxel in Solid TumorsCompletedNCT01837667Phase 1
- A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric CancerStatus unknownNCT01836120Phase 2
- Trastuzumab & Pertuzumab Followed by T-DM1 in MBCCompletedNCT01835236Phase 2
- Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric CancerTerminatedNCT01830270Phase 2
- IST Neoadjuvant Abraxane in Newly Diagnosed Breast CancerStatus unknownNCT01830244Phase 2
- Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)Status unknownNCT01830231Phase 2/3
- Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast CancerCompletedNCT01822314Phase 3
- The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial CarcinomaActive, not recruitingNCT01820858Phase 3
- Ixabepilone and SBRT For Metastatic Breast CancerWithdrawnNCT01818999Phase 2
- A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01812746Phase 2
- Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaStatus unknownNCT01812018Phase 2
- Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerSuspendedNCT01810913Phase 2/3
- Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer PatientsCompletedNCT01802970Phase 1
- The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRTCompletedNCT01797900Phase 2
- A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast PatientsCompletedNCT01795586Phase 1
- A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung CancerCompletedNCT01792479Phase 2
- Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast CancerCompletedNCT01792050Phase 2
- A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma PatientsStatus unknownNCT01788137Phase 3
- A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast CancerStatus unknownNCT01784120Phase 2
- Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE)CompletedNCT01779479Phase 2
- ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast CancerCompletedNCT01779206Phase 2/3
- Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian CancerCompletedNCT01778803Phase 1
- Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary CancerTerminatedNCT01773785Phase 2
- A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung CancerCompletedNCT01770795Phase 2
- A Study of KX2-391 With Paclitaxel in Patients With Solid TumorsStatus unknownNCT01764087Phase 1/2
- Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast CancerCompletedNCT01763710Phase 2
- Paclitaxel-bevacizumab in Advanced Lung CancerCompletedNCT01763671Phase 3
- Dose Adjusted EPOCH-R, to Treat Mature B Cell MalignanciesCompletedNCT01760226Early Phase 1
- Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer PatientsStatus unknownNCT01756170Phase 3
- A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer PatientsCompletedNCT01755897Not applicable
- Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer PatientsStatus unknownNCT01755845Phase 3
- A Dose Finding Study of XRP6258 in Patients With Advanced Solid TumorsCompletedNCT01755390Phase 1
- Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate CancerWithdrawnNCT01750866Phase 2
- Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer PatientsStatus unknownNCT01749072Phase 2
- Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction CancerStatus unknownNCT01747707Phase 2
- Cabazitaxel in Platinum Refractory Ovarian CancerTerminatedNCT01747239Phase 2
- A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric CancerCompletedNCT01746771Phase 1/2
- Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs TherapyStatus unknownNCT01746277Phase 2
- Phase I/II Cabazitaxel for Recurrent Malignant GliomaWithdrawnNCT01740570Phase 1/2
- Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS LymphomaStatus unknownNCT01735747Phase 2
- Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/TrastuzumabStatus unknownNCT01730677Phase 2
- NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)CompletedNCT01726452Phase 3
- Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue SarcomaCompletedNCT01719302Phase 1/2
- Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic CancerCompletedNCT01715142Early Phase 1
- A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian CancerCompletedNCT01711970Phase 1/2
- An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT01711697Phase 1
- Salvage Docetaxel for Pretreated Urothelial CancerCompletedNCT01711112Phase 2
- A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal CancerCompletedNCT01710592Phase 2
- Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage TherapyCompletedNCT01708993Phase 2
- Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With BevacizumabStatus unknownNCT01706120Phase 4
- A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic MalignanciesTerminatedNCT01705483Phase 1
- Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal CancerTerminatedNCT01704690Phase 2/3
- A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic DiseaseWithdrawnNCT01702714Phase 1
- Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid CancerWithdrawnNCT01701349Phase 3
- Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial CancerWithdrawnNCT01700010Phase 2
- PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerTerminatedNCT01697293Phase 1/2
- NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent ChemoradiationTerminatedNCT01694576Phase 2
- Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With TaxanesCompletedNCT01693549Phase 2
- Docetaxel and S-1 for Advanced Esophageal CancerStatus unknownNCT01693432Phase 2
- Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic CancerTerminatedNCT01693276Phase 1/2
- Study of Nab-Paclitaxel in High Risk Early Breast CancerCompletedNCT01690702Phase 3
- An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1)CompletedNCT01684111Phase 1
- An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2)CompletedNCT01683682Phase 1
- Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid MalignanciesCompletedNCT01677559Phase 1
- Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV MelanomaActive, not recruitingNCT01676649Phase 2
- A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT01676259Phase 2